Skip to content

Moderna

US · MRNA #406 by market cap Listed 2018
195.00 -4.33 -2.17%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Quant vs Street three independent views, side by side

StockVane factor grade
D
Momentum strategy signal
Hold
Analyst consensus
Hold

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

✦ Quant Analyst Revision Trend how this is computed

Improving
4 2
■ Upgrades■ Downgrades
  • 4 upgrades vs 2 downgrades among tracked analyst rating changes.
  • The single most recent change was actually a downgrade (William Blair moved from Buy to Hold on 2026-10-27), though the broader window skews toward upgrades.

Analyst consensus 10 analysts

Hold
Avg price target 171.63 -12.0%
Price target rangecurrent 195.00
Low80.00
Avg171.63
High305.00
Buy 20% Hold 50% Sell 30%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-19 Jefferies -- Hold 215.00
2026-11-16 J.P. Morgan -- Sell 102.00
2026-11-13 Piper Sandler -- Buy 305.00
2026-11-12 BofA Securities -- Hold 260.00
2026-11-12 Citi -- Sell 80.00
2026-11-09 Piper Sandler -- Buy 305.00
2026-11-09 Citi -- Sell 80.00
2026-11-06 BofA Securities -- Hold 260.00
2026-10-27 William Blair -- Hold --
2026-10-27 BofA Securities -- Hold 220.00
2026-10-27 Citi -- Sell 80.00
2026-10-26 Piper Sandler -- Buy 230.00
2026-10-26 BofA Securities -- Hold 220.00
2026-10-26 Citi -- Sell 80.00
2026-10-23 Citi -- Sell 80.00
2026-10-22 Citi -- Sell 80.00
2026-10-19 BofA Securities -- Hold 220.00
2026-10-15 Citi -- Sell 80.00
2026-10-09 BofA Securities -- Hold --
2026-10-01 Citi -- Sell 80.00
2026-09-28 J.P. Morgan -- Sell --
2026-09-18 BofA Securities -- Hold 170.00
2026-09-11 DBS -- Hold 150.00
2026-09-03 Rothschild & Co Redburn -- Sell 81.00
2026-08-27 Argus Research -- Buy 180.00

Price target trend monthly average, last 3 years

Recent rating changes

DateFirmChangeTarget
2026-10-27 William Blair Buy → Hold --
2026-10-01 Citi Hold → Sell 80.00
2026-08-27 Argus Research Hold → Buy 180.00
2026-08-25 Wolfe Research Sell → Hold --
2026-08-19 BofA Securities Sell → Hold 170.00
2026-08-19 William Blair Hold → Buy --

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q3 2026-11-06 -- ±13.77% +5.27% (in line)
2026/Q2 2026-07-31 -- ±11.26% -5.35% (in line)
2026/Q1 2026-05-01 -- ±10.92% -1.24% (in line)
2025/Q4 2026-02-13 -- ±11.63% +5.29% (in line)
2025/Q3 2025-11-06 -- ±7.85% +3.27% (in line)
2025/Q2 2025-08-01 -- ±12.30% -6.61% (in line)
2025/Q1 2025-05-01 -- ±10.85% -5.29% (in line)
2024/Q4 2025-02-14 -- ±12.56% +3.35% (in line)
2024/Q3 2024-11-07 -- ±13.55% -2.95% (in line)
2024/Q2 2024-08-01 -- ±8.25% -21.01% (beat)
2024/Q1 2024-05-02 -- ±7.67% +12.68% (beat)
2023/Q4 2024-02-22 -- ±9.84% +13.53% (beat)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 20:02:37 · For reference only, not investment advice and not tailored to your situation.

Moderna discussion 0 comments

Add a comment